Prosecution Insights
Last updated: April 19, 2026
Application No. 17/140,033

INTEGRATED SYSTEMS FOR PREDETERMINED COMBINATION LASER-PHACOEMULSIFICATION THERAPIES

Non-Final OA §112
Filed
Jan 01, 2021
Examiner
FARAH, AHMED M
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Lensar Inc.
OA Round
3 (Non-Final)
79%
Grant Probability
Favorable
3-4
OA Rounds
3y 7m
To Grant
98%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allow Rate
1040 granted / 1320 resolved
+8.8% vs TC avg
Strong +19% interview lift
Without
With
+18.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
12 currently pending
Career history
1332
Total Applications
across all art units

Statute-Specific Performance

§101
3.0%
-37.0% vs TC avg
§103
29.1%
-10.9% vs TC avg
§102
23.5%
-16.5% vs TC avg
§112
28.3%
-11.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1320 resolved cases

Office Action

§112
DETAILED ACTION A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on December 2nd 2025 has been entered. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 60 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 60 recites “the system of any of claims 37 to 48, wherein the system comprises a means for grading cataracts. The applicant’s amendment filed on 12/02/2025 canceled claim 43. Hence, claim 60 is ambiguous because it explicitly lists the cancelled claim. The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claim 60 is rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claim 60 further recites “the system of any of claims 37 to 48, wherein the system comprises a means for grading cataracts.” Claim 43 was cancelled, and claims 37-42 and 44-48 all rely on independent claim 1, which describes a means/control system for determining the level of cataracts (“a means for determining a shape, a position or both of a structure of an eye; wherein the means for determining is configured to provide information to a control system; wherein the control system is configured to determine a cataract grade”). Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Allowable Subject Matter Claims 1-16, 37-42, 44-48, 54-59, and 61-72 are allowed. The following is a statement of reasons for the indication of allowable subject matter: the prior art of record does not disclose or suggest a device that provides information to a control system to determine a cataract grade, and provide a suggested laser/ phacoemulsification treatment or both, based at least in part upon the cataract grade as claimed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to AHMED M FARAH whose telephone number is (571)272-4765. The examiner can normally be reached Mon - Fri. 9:30AM -10:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Niketa Patel can be reached at 571-272-4156. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AHMED M FARAH/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Jan 01, 2021
Application Filed
Jul 13, 2024
Non-Final Rejection — §112
Feb 19, 2025
Response Filed
May 29, 2025
Final Rejection — §112
Dec 02, 2025
Request for Continued Examination
Jan 30, 2026
Response after Non-Final Action
Feb 03, 2026
Non-Final Rejection — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594032
WEARABLE HEMODYNAMIC MONITORING DEVICE AND SYSTEM
2y 5m to grant Granted Apr 07, 2026
Patent 12594299
PHOTOSYNTHETIC CELLULAR SUBSTANCES AND METHODS OF USE THEREOF
2y 5m to grant Granted Apr 07, 2026
Patent 12594435
INTERSTITIAL PHOTODYNAMIC THERAPY
2y 5m to grant Granted Apr 07, 2026
Patent 12594189
LONG-TERM MONITORING OF THE INCISION PERFORMANCE OF AN OPHTHALMIC LASER SURGICAL SYSTEM
2y 5m to grant Granted Apr 07, 2026
Patent 12589033
LASER METHODS AND SYSTEMS FOR ADDRESSING CONDITIONS OF THE LENS
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
79%
Grant Probability
98%
With Interview (+18.8%)
3y 7m
Median Time to Grant
High
PTA Risk
Based on 1320 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month